Can Pulmonary Embolism Severity Indices Predict COVID-19-Related Adverse Events?
Can the pulmonary embolism severity index assess the risk for adverse events among patients hospitalized for COVID-19 who are not diagnosed with PE or VTE?
All articles by Bradley van Paridon
Diagnosing OSA in Children: Are Single Night Sleep Studies Accurate?
In children, does night-to-night variability in sleep parameters affect the accuracy of single-night sleep tests in diagnosing OSA?
Dupilumab for Chronic Rhinosinusitis Improves Likelihood of Symptom-Free Days
Researchers assessed the proportion of patients with severe chronic rhinosinusitis with nasal polyps who received dupilumab and experienced symptom-free days.
Use of Best Practice Advisory Helps Identify Patients With Difficult Airways
Can a best practice advisory can improve difficult airway documentation in electronic health records of patients at risk for difficult intubation?
Children With Obstructive Sleep-Disordered Breathing Experience Care Inequities
Researchers sought to examine the drivers behind treatment inequities in children with obstructive sleep-disordered breathing.
Sick Building Syndrome and Ocular Allergy: What Cytokine Profiles Show
To what extent is sick building syndrome an allergic reaction? Researchers examined cytokine production profiles of patients with ocular manifestations of SBS.
Clinical Prediction Models For Inpatients With COVID-19: Do They Work?
Which prognostic models or indicators effectively predict critical care outcomes among patients hospitalized for COVID-19 pneumonia?
Dolutegravir Twice Daily Optimal for Children With HIV-Associated Tuberculosis on Rifampicin
Researchers assessed the safety and effectiveness of twice-daily dolutegravir dosing plus rifampicin in children with HIV-associated tuberculosis infection.
Percutaneous Thrombectomy Outcomes in Female vs Male Patients With PE
Do female patients undergoing percutaneous thrombectomy for pulmonary embolism experience worse morbidity and mortality rates than male patients?
How Effective is Clofazimine in Treating Multidrug-Resistant Tuberculosis?
Should clofazimine remain a “second-choice agent” for treating patients with multidrug-resistant tuberculosis? A meta-analysis reviews the current evidence.
- Loading...
Loading...
Next post in Tuberculosis
Loading... 
Loading...